A clinical review of eyelid sebaceous carcinoma.
- Author:
Jun Hee BYEON
1
;
Won Seok YUM
;
Jong Won RHIE
;
Chong Kun LEE
;
Poong LIM
Author Information
1. Department of Plastic Surgery, The Catholic University of Korea, College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Malignant eyelid tumor;
Sebaceous gland carcinoma
- MeSH:
Biopsy;
Brain;
Carcinoma, Basal Cell;
Carcinoma, Squamous Cell;
Chalazion;
Conjunctivitis;
Delayed Diagnosis;
Diagnosis;
Eyelids*;
Frozen Sections;
Mortality;
Paranasal Sinuses;
Recurrence;
Sebaceous Glands
- From:Journal of the Korean Society of Plastic and Reconstructive Surgeons
1998;25(3):446-452
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Malignant tumors of the eyelid pose a serious threat because of their proximity to the globe, brain & paranasal sinuses. Three types of carcinomas account for the vast majority of the malignant eyelid tumors: basal cell carcinoma, squamous cell carcinoma, and sebaceous gland carcinoma. In these malignancies, basal cell carcinoma is the most common. However, sebaceous gland carcinoma has a high recurrence rate and a moderately high 5-year mortality rate because of late diagnosis and incomplete surgical removal. This tumor may be clinically misdiagnosed frequently as a chronic unilateral conjunctivitis, chalazion, basal cell carcinoma, or squamous cell carcinoma in initial biopsy. Suspicious lid lesions should be managed with incisional biopsy initially. If they are positive for sebaceous gland carcinoma, wide excision and frozen section monitoring of surgical margin is the treatment of choice. The final diagnosis should be confirmed by special stain for lipid. We experienced 12 cases of malignant eyelid tumors including 3 cases of sebaceous gland carcinoma. In cases of sebaceous gland carcinoma, wide surgical excision with frozen section monitoring was performed and followed by eyelid reconstruction with intact eyelid tissue remained and adjuvant radiotheraphy. Guidelines for management are discussed.
